Fei Huang

Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma

Qiwen Chen, Shu Dong, Fei Huang, 2019, Bioscience reports.

Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast Cancer

Hu Chen, D. Tonetti, Huiping Zhao, 2020 .

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

A. Rana, K. Ratia, J. Trevino, 2022, Proceedings of the National Academy of Sciences.

Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer.

A. Wolff, D. Nuyten, F. Huang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.